Allianz’s ResMed RMD Stock Holding History

Allianz’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.4K	Sell	156 -10	-6%	-$2.07K	﹤0.01%	451
2026 Q1	$37.3K	Hold	166	–	–	﹤0.01%	419
2025 Q4	$40K	Hold	166	–	–	﹤0.01%	396
2025 Q3	$45.4K	Sell	166 -418	-72%	-$114K	﹤0.01%	335
2025 Q2	$151K	Sell	584 -533	-48%	-$127K	﹤0.01%	317
2025 Q1	$250K	Sell	1,117 -513	-31%	-$120K	0.01%	300
2024 Q4	$373K	Buy	+1,630	New	+$392K	0.01%	284
2024 Q3	–	Sell	-1,630	Closed	-$312K	–	450
2024 Q2	$312K	Sell	1,630 -5,870	-78%	-$1.19M	0.01%	299
2024 Q1	$1.49M	Buy	+7,500	New	+$1.37M	0.05%	194

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Allianz's RMD Position: Q2 2026 in Review

Allianz reduced its ResMed (RMD) stake by 6% in Q2 2026, selling an estimated $2.07K and leaving 156 shares worth $30.4K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Allianz first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.49M in Q1 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Allianz held 156 shares of ResMed worth $30.4K as of Q2 2026.
Allianz sold 10 ResMed shares in Q2 2026, an estimated $2.07K.
ResMed made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #451 holding.
Allianz first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
Allianz's ResMed position peaked at $1.49M in Q1 2024.
885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.